While the use of rhGH is federally restricted to specific, FDA-approved conditions, sermorelin is not a controlled substance and is not prohibited for off-label use in adults
However, the source of Vitamin E and glutathione also needs to carefully considered, since some kidney patients may need to limit the intake of certain nutrients to avoid causing further damage to their kidneys
Other important safety considerations include: Tirzepatide is not recommended in patients with severe gastrointestinal disease, including severe gastroparesis [3] [4] Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these agents may be required) Potential for gallbladder disease (cholelithiasis, cholecystitis) Risk of dehydration leading to acute kidney injury Reduced exposure to oral contraceptives (additional contraception recommended for 4 weeks after initiation and after each dose increase) Patients should report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
If approved, patients may discuss insurance coverage, self-pay options, prescription fulfillment, and medication delivery
Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: a double-blind placebo-controlled study
Wegovy addresses physiological hunger but does not eliminate psychological drivers of eating behaviour
